Humana's bid on Ambea ends; Ambea holds 98% stake, no extension

Ambea's takeover bid for Humana has concluded with Ambea controlling 98% of Humana, and the acceptance period will not be extended. This marks the end of the acquisition process, likely leading to compulsory acquisition of remaining shares. The outcome is a corporate control event with limited broader market impact.